| Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ... EBioMedicine 38, 100-112, 2018 | 178 | 2018 |
| The extracellular RNA communication consortium: establishing foundational knowledge and technologies for extracellular RNA research S Das, AB Abdel-Mageed, C Adamidi, PD Adelson, KM Akat, E Alsop, ... Cell 177 (2), 231-242, 2019 | 176 | 2019 |
| Ubiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cells P Kanlikilicer, MH Rashed, R Bayraktar, R Mitra, C Ivan, B Aslan, X Zhang, ... Cancer research 76 (24), 7194-7207, 2016 | 129 | 2016 |
| MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase R Bayraktar, M Pichler, P Kanlikilicer, C Ivan, E Bayraktar, N Kahraman, ... Oncotarget 8 (7), 11641, 2017 | 119 | 2017 |
| Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer B Marc D., S Andreia M., P Kanlikilicer-Unaldi, J Filant, MH Rashed, ... Non-Coding RNA 1 (1), 53-68, 2015 | 91 | 2015 |
| GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma AA El-Arabey, M Denizli, P Kanlikilicer, R Bayraktar, C Ivan, M Rashed, ... Cellular signalling 68, 109539, 2020 | 90 | 2020 |
| Rac1/Pak1/p38/MMP-2 axis regulates angiogenesis in ovarian cancer V Gonzalez-Villasana, E Fuentes-Mattei, C Ivan, HJ Dalton, ... Clinical cancer research 21 (9), 2127-2137, 2015 | 80 | 2015 |
| Dual suppressive effect of miR-34a on the FOXM1/eEF2-kinase axis regulates triple-negative breast cancer growth and invasion R Bayraktar, C Ivan, E Bayraktar, P Kanlikilicer, NN Kabil, N Kahraman, ... Clinical Cancer Research 24 (17), 4225-4241, 2018 | 79 | 2018 |
| Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs MH Rashed, P Kanlikilicer, C Rodriguez-Aguayo, M Pichler, R Bayraktar, ... Oncotarget 8 (12), 20145, 2017 | 63 | 2017 |
| Therapeutic targeting of AXL receptor tyrosine kinase inhibits tumor growth and intraperitoneal metastasis in ovarian cancer models P Kanlikilicer, B Ozpolat, B Aslan, R Bayraktar, N Gurbuz, ... Molecular Therapy-Nucleic Acids 9, 251-262, 2017 | 62 | 2017 |
| The ZNF304-integrin axis protects against anoikis in cancer B Aslan, P Monroig, MC Hsu, GA Pena, C Rodriguez-Aguayo, ... Nature communications 6 (1), 7351, 2015 | 58 | 2015 |
| ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer A Gorur, R Bayraktar, C Ivan, HA Mokhlis, E Bayraktar, N Kahraman, ... Molecular Therapy-Nucleic Acids 23, 930-943, 2021 | 31 | 2021 |
| The modulatory role of MicroRNA-873 in the progression of KRAS-driven cancers HA Mokhlis, R Bayraktar, NN Kabil, A Caner, N Kahraman, ... Molecular Therapy-Nucleic Acids 14, 301-317, 2019 | 29 | 2019 |
| Investigating the effect of perinatal nicotine exposure on dopaminergic neurons in the VTA using miRNA expression profiles RF Keller, P Kanlikilicer, A Dragomir, Y Fan, YM Akay, M Akay IEEE transactions on nanobioscience 16 (8), 843-849, 2017 | 20 | 2017 |
| Communication between the active site and the allosteric site in class A beta-lactamases D Meneksedag, A Dogan, P Kanlikilicer, E Ozkirimli Computational Biology and Chemistry 43, 1-10, 2013 | 18 | 2013 |
| Gene expression profiling of midbrain dopamine neurons upon gestational nicotine exposure P Kanlikilicer, D Zhang, A Dragomir, YM Akay, M Akay Medical & biological engineering & computing 55, 467-482, 2017 | 16 | 2017 |
| Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine. 2018; 38: 100–12 P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ... Epub 2018/11/30. https://doi. org/10.1016/j. ebiom. 2018.11. 004 PMID: 30487062, 0 | 8 | |
| Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’[EBioMedicine 38 (2018) 100–112] P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ... EBioMedicine 52, 2020 | 6 | 2020 |
| CORRIGENDUM: GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma (Cellular Signalling (2020) 68 … AA El-Arabey, M Denizli, P Kanlikilicer, R Bayraktar, C Ivan, M Rashed, ... Cellular Signalling 89, 110147, 2022 | 3 | 2022 |
| Exosome-related methods and potential use as vaccines P Kanlikilicer Cancer Immunoprevention: Methods and Protocols, 35-41, 2022 | 2 | 2022 |
